Direxion Daily S&P Biotech Bull 3X ETF
LABU
17 hedge funds and large institutions have $48.3M invested in Direxion Daily S&P Biotech Bull 3X ETF in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 6 closing their positions.
87% more capital inflows, than outflows
Capital inflows: $15.8M | Capital outflows: $8.46M
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
2.28% more ownership
Funds ownership: 12.18% → 14.45% (+2.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less call options, than puts
Call options by funds: $42.1M | Put options by funds: $43M
6% less funds holding
Funds holding: 18 → 17 (-1)
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$6.63M |
| 2 |
HJMC
Hellman Jordan Management Company
Quincy,
Massachusetts
|
+$2.77M |
| 3 |
Exencial Wealth Advisors
Oklahoma City,
Oklahoma
|
+$1.95M |
| 4 |
Morgan Stanley
New York
|
+$1.57M |
| 5 |
Tower Research Capital (TRC)
New York
|
+$1.02M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$3.47M |
| 2 |
Credit Suisse
Zurich,
Switzerland
|
-$3.15M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$999K |
| 4 |
Two Sigma Securities
New York
|
-$260K |
| 5 |
Traynor Capital Management
Malvern,
Pennsylvania
|
-$180K |
LABU Hedge Fund Activity: Q3 2017 in Review
17 of the 4,023 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bull 3X ETF (LABU) for Q3 2017, worth a combined $48.3M — up 65% from $29.3M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of LABU and 5 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 6 added.
The largest buyer was Jane Street, adding an estimated $6.63M. The largest seller was Citigroup, cutting an estimated $3.47M.
- 17 institutional investors held Direxion Daily S&P Biotech Bull 3X ETF (LABU) as of Q3 2017, down from 18 in Q2 2017.
- Funds reported $48.3M of Direxion Daily S&P Biotech Bull 3X ETF stock for Q3 2017, up 65% quarter-over-quarter.
- 5 funds opened new Direxion Daily S&P Biotech Bull 3X ETF positions in Q3 2017 and 6 closed out, a net change of -1 holder.
- The largest Direxion Daily S&P Biotech Bull 3X ETF buyer in Q3 2017 was Jane Street, an estimated $6.63M added.
- The largest Direxion Daily S&P Biotech Bull 3X ETF seller in Q3 2017 was Citigroup, an estimated $3.47M sold.
Based on aggregated 13F filings for Q3 2017.